Galanthamine and Non-competitive Inhibitor Binding to ACh-binding Protein: Evidence for a Binding Site on Non-α-subunit Interfaces of Heteromeric Neuronal Nicotinic Receptors-Reference-Cited by-同舟云学术

Galanthamine and Non-competitive Inhibitor Binding to ACh-binding Protein: Evidence for a Binding Site on Non-α-subunit Interfaces of Heteromeric Neuronal Nicotinic Receptors

Published:2007-06 Issue:4 Volume:369 Page:895-901
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Hansen Scott B.,Taylor Palmer

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference38 articles.

1. Nicotinic Acetylcholine Receptors: from Molecular Biology to Cognition;Changeux,2005

2. Unconventional ligands and modulators of nicotinic receptors;Pereira;J. Neurobiol.,2002

3. Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine;Giraudat;Proc. Natl Acad. Sci. USA,1986

4. The reaction site of a non-competitive antagonist in the delta-subunit of the nicotinic acetylcholine receptor;Oberthur;EMBO J.,1986

5. Structure of the noncompetitive antagonist-binding site of the Torpedo nicotinic acetylcholine receptor. [3H]meproadifen mustard reacts selectively with alpha-subunit Glu-262;Pedersen;J. Biol. Chem.,1992

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient Expression in Leishmania tarentolae (LEXSY) of the Receptor-Binding Domain of the SARS-CoV-2 S-Protein and the Acetylcholine-Binding Protein from Lymnaea stagnalis;Molecules;2024-02-21

2. What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders;Journal of Medicinal Chemistry;2022-11-28

3. The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy;Breast Cancer;2022-05-18

4. Pathophysiology, Molecular Interaction Mechanism, Metabolism, Pharmacotherapy and New Perspectives in the Pharmacological Treatment of Chemical Dependence on the Main Illicit Drugs Consumed in the World;Research Topics in Bioactivity, Environment and Energy;2022

5. Lessons from nature: Structural studies and drug design driven by a homologous surrogate from invertebrates, AChBP;Neuropharmacology;2020-11